Literature DB >> 23168319

Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease.

Rashmee U Shah1, Tara I Chang, Gregg C Fonarow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23168319      PMCID： PMC4125574          DOI： 10.1016/j.hfc.2012.09.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


× No keyword cloud information.
  73 in total

1.  Polypharmacy and comorbidity in heart failure.

Authors:  Frederick A Masoudi; Harlan M Krumholz
Journal:  BMJ       Date:  2003-09-06

2.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

3.  Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.

Authors:  Frederick A Masoudi; Edward P Havranek; Pam Wolfe; Cary P Gross; Saif S Rathore; John F Steiner; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

4.  Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

Authors:  Finlay A McAlister; Justin Ezekowitz; Marcello Tonelli; Paul W Armstrong
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

5.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors:  John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

6.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors:  Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

7.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Authors:  Christopher B Granger; John J V McMurray; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Marc A Pfeffer; Karl Swedberg
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

8.  Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.

Authors:  Michael G Shlipak; Grace L Smith; Saif S Rathore; Barry M Massie; Harlan M Krumholz
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

9.  Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.

Authors:  Prakash C Deedwania; Stephen Gottlieb; Jalal K Ghali; Finn Waagstein; John C M Wikstrand
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

10.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Authors:  A Hjalmarson; S Goldstein; B Fagerberg; H Wedel; F Waagstein; J Kjekshus; J Wikstrand; D El Allaf; J Vítovec; J Aldershvile; M Halinen; R Dietz; K L Neuhaus; A Jánosi; G Thorgeirsson; P H Dunselman; L Gullestad; J Kuch; J Herlitz; P Rickenbacher; S Ball; S Gottlieb; P Deedwania
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272
View more
  2 in total

1.  Capsule Commentary on Al-Khatib et al., Future Research Prioritization: Implantable Cardioverter Defibrillator Therapy in Older Patients.

Authors:  Nicoletta Riva; Christian Borg Xuereb
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

Review 2.  Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.

Authors:  Ronée E Harvey; Kirsten E Coffman; Virginia M Miller
Journal:  Womens Health (Lond)       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.